-
1
-
-
50849118127
-
Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease
-
Adams F, Boschmann M, Lobsien E, Kupsch A, Lipp A, Franke G, Leisse MC, Janke J, Gottschalk S, Spranger J, Jordan J. 2008. Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease. Eur J Clin Pharmacol 64:863-870.
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 863-870
-
-
Adams, F.1
Boschmann, M.2
Lobsien, E.3
Kupsch, A.4
Lipp, A.5
Franke, G.6
Leisse, M.C.7
Janke, J.8
Gottschalk, S.9
Spranger, J.10
Jordan, J.11
-
2
-
-
84866735656
-
Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity
-
Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, Kristiansen K, Frøyland L, Hibbeln JR. 2012. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) 20:1984-1994.
-
(2012)
Obesity (Silver Spring)
, vol.20
, pp. 1984-1994
-
-
Alvheim, A.R.1
Malde, M.K.2
Osei-Hyiaman, D.3
Lin, Y.H.4
Pawlosky, R.J.5
Madsen, L.6
Kristiansen, K.7
Frøyland, L.8
Hibbeln, J.R.9
-
3
-
-
0035889980
-
Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain
-
Andreeva SG, Dikkes P, Epstein PM, Rosenberg PA. 2001. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci 21:9068-9076.
-
(2001)
J Neurosci
, vol.21
, pp. 9068-9076
-
-
Andreeva, S.G.1
Dikkes, P.2
Epstein, P.M.3
Rosenberg, P.A.4
-
4
-
-
0034069495
-
Gene ontology: Tool for the unification of biology
-
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29.
-
(2000)
The Gene Ontology Consortium. Nat Genet
, vol.25
, pp. 25-29
-
-
Ashburner, M.1
Ball, C.A.2
Blake, J.A.3
Botstein, D.4
Butler, H.5
Cherry, J.M.6
Davis, A.P.7
Dolinski, K.8
Dwight, S.S.9
Eppig, J.T.10
Harris, M.A.11
Hill, D.P.12
Issel-Tarver, L.13
Kasarskis, A.14
Lewis, S.15
Matese, J.C.16
Richardson, J.E.17
Ringwald, M.18
Rubin, G.M.19
Sherlock, G.20
more..
-
5
-
-
0035932974
-
Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
-
Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. 2001. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 98:6402-6406.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 6402-6406
-
-
Berger, A.1
Crozier, G.2
Bisogno, T.3
Cavaliere, P.4
Innis, S.5
Di Marzo, V.6
-
6
-
-
0035434121
-
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
-
Bezard E, Brotchie JM, Gross CE. 2001. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies. Nat Rev Neurosci 2:577-588.
-
(2001)
Nat Rev Neurosci
, vol.2
, pp. 577-588
-
-
Bezard, E.1
Brotchie, J.M.2
Gross, C.E.3
-
7
-
-
0034287012
-
Functional changes of the basal ganglia circuitry in Parkinson's disease
-
Blandini F, Nappi G, Tassorelli C, Martignoni E. 2000. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 62:63-88.
-
(2000)
Prog Neurobiol
, vol.62
, pp. 63-88
-
-
Blandini, F.1
Nappi, G.2
Tassorelli, C.3
Martignoni, E.4
-
8
-
-
84890068169
-
l-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus
-
Bonaventura J, Rico AJ, Moreno E, Sierra S, Sánchez M, Luquin N, Farré D, Müller CE, Martínez-Pinilla E, Cortés A, Mallol J, Armentero MT, Pinna A, Canela EI, Lluís C, McCormick PJ, Lanciego JL, Casadó V, Franco R. 2013. l-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus. Neuropharmacology 79C:90-100.
-
(2013)
Neuropharmacology
, vol.79 C
, pp. 90-100
-
-
Bonaventura, J.1
Rico, A.J.2
Moreno, E.3
Sierra, S.4
Sánchez, M.5
Luquin, N.6
Farré, D.7
Müller, C.E.8
Martínez-Pinilla, E.9
Cortés, A.10
Mallol, J.11
Armentero, M.T.12
Pinna, A.13
Canela, E.I.14
Lluís, C.15
McCormick, P.J.16
Lanciego, J.L.17
Casadó, V.18
Franco, R.19
-
9
-
-
0035784037
-
Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat
-
Breit S, Bouali-Benazzouz R, Benabid A, Benazzouz A. 2001. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur J Neurosci 14:1833-1842.
-
(2001)
Eur J Neurosci
, vol.14
, pp. 1833-1842
-
-
Breit, S.1
Bouali-Benazzouz, R.2
Benabid, A.3
Benazzouz, A.4
-
10
-
-
53149129843
-
Molecular mechanisms underlying levodopa-induced dyskinesia
-
Calabresi P, Di Filippo M, Ghiglieri V, Picconi B. 2008. Molecular mechanisms underlying levodopa-induced dyskinesia. Mov Disord 23 (Suppl 3):S570-S579.
-
(2008)
Mov Disord
, vol.23
, Issue.SUPPL 3
-
-
Calabresi, P.1
Di Filippo, M.2
Ghiglieri, V.3
Picconi, B.4
-
11
-
-
77957966489
-
Levodopa-induced dyskinesias in patients with Parkinson's disease: Filling the bench-to-bedside gap
-
Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B. 2010. Levodopa-induced dyskinesias in patients with Parkinson's disease: Filling the bench-to-bedside gap. Lancet Neurol 9:1106-1117.
-
(2010)
Lancet Neurol
, vol.9
, pp. 1106-1117
-
-
Calabresi, P.1
Di Filippo, M.2
Ghiglieri, V.3
Tambasco, N.4
Picconi, B.5
-
12
-
-
0000428532
-
3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists
-
Carlsson A, Lindqvist M, Magnusson T. 1957. 3, 4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200.
-
(1957)
Nature
, vol.180
, pp. 1200
-
-
Carlsson, A.1
Lindqvist, M.2
Magnusson, T.3
-
14
-
-
84885107433
-
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats
-
Chaves-Kirsten GP, Mazucanti CH, Real CC, Souza BM, Britto LR, Torrão AS. 2013. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats. PLoS One 8:e76874.
-
(2013)
PLoS One
, vol.8
-
-
Chaves-Kirsten, G.P.1
Mazucanti, C.H.2
Real, C.C.3
Souza, B.M.4
Britto, L.R.5
Torrão, A.S.6
-
16
-
-
0036283426
-
Modeling Parkinson's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway
-
Deumens R, Blokland A, Prickaerts J. 2002. Modeling Parkinson's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303-317.
-
(2002)
Exp Neurol
, vol.175
, pp. 303-317
-
-
Deumens, R.1
Blokland, A.2
Prickaerts, J.3
-
17
-
-
0033936028
-
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
-
Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. 2000. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14:1432-1438.
-
(2000)
FASEB J
, vol.14
, pp. 1432-1438
-
-
Di Marzo, V.1
Hill, M.P.2
Bisogno, T.3
Crossman, A.R.4
Brotchie, J.M.5
-
18
-
-
35348890683
-
On testing the significance of sets of genes
-
Efron B, Tibshirani R. 2007. On testing the significance of sets of genes. Ann Appl Stat 1:107-129.
-
(2007)
Ann Appl Stat
, vol.1
, pp. 107-129
-
-
Efron, B.1
Tibshirani, R.2
-
19
-
-
0034109726
-
The spectrum of levodopa-induced dyskinesias
-
discussion S9-S11.
-
Fahn S. 2000. The spectrum of levodopa-induced dyskinesias. Ann Neurol 47(Suppl 1):S2-S9; discussion S9-S11.
-
(2000)
Ann Neurol
, vol.47
, Issue.SUPPL 1
-
-
Fahn, S.1
-
20
-
-
0034653210
-
Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
-
Fenton WS, Hibbeln J, Knable M. 2000. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47:8-21.
-
(2000)
Biol Psychiatry
, vol.47
, pp. 8-21
-
-
Fenton, W.S.1
Hibbeln, J.2
Knable, M.3
-
21
-
-
0141481993
-
Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias
-
Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A. 2003. Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18:1607-1614.
-
(2003)
Eur J Neurosci
, vol.18
, pp. 1607-1614
-
-
Ferrer, B.1
Asbrock, N.2
Kathuria, S.3
Piomelli, D.4
Giuffrida, A.5
-
22
-
-
52449135495
-
Pathophysiology of parkinsonism
-
Galvan A, Wichmann T. 2008. Pathophysiology of parkinsonism. Clin Neurophysiol 119:1459-1474.
-
(2008)
Clin Neurophysiol
, vol.119
, pp. 1459-1474
-
-
Galvan, A.1
Wichmann, T.2
-
23
-
-
0035176184
-
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
-
Gerdeman G, Lovinger DM. 2001. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85:468-471.
-
(2001)
J Neurophysiol
, vol.85
, pp. 468-471
-
-
Gerdeman, G.1
Lovinger, D.M.2
-
24
-
-
0036233834
-
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
-
Gerdeman GL, Ronesi J, Lovinger DM. 2002. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446-451.
-
(2002)
Nat Neurosci
, vol.5
, pp. 446-451
-
-
Gerdeman, G.L.1
Ronesi, J.2
Lovinger, D.M.3
-
25
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
-
Huang dW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
-
(2009)
Nat Protoc
, vol.4
, pp. 44-57
-
-
Huang, dW.1
Sherman, B.T.2
Lempicki, R.A.3
-
26
-
-
0345490815
-
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
-
Hurley MJ, Mash DC, Jenner P. 2003. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. J Neural Transm 110:1279-1288.
-
(2003)
J Neural Transm
, vol.110
, pp. 1279-1288
-
-
Hurley, M.J.1
Mash, D.C.2
Jenner, P.3
-
27
-
-
33847210742
-
A perspective on microarrays: current applications, pitfalls, and potential uses
-
Jaluria P, Konstantopoulos K, Betenbaugh M, Shiloach J. 2007. A perspective on microarrays: current applications, pitfalls, and potential uses. Microb Cell Fact 6:4.
-
(2007)
Microb Cell Fact
, vol.6
, pp. 4
-
-
Jaluria, P.1
Konstantopoulos, K.2
Betenbaugh, M.3
Shiloach, J.4
-
28
-
-
50049087567
-
Molecular mechanisms of l-DOPA-induced dyskinesia
-
Jenner P. 2008. Molecular mechanisms of l-DOPA-induced dyskinesia. Nat Rev Neurosci 9:665-677.
-
(2008)
Nat Rev Neurosci
, vol.9
, pp. 665-677
-
-
Jenner, P.1
-
29
-
-
33644648536
-
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys
-
Julien C, Berthiaume L, Hadj-Tahar A, Rajput AH, Bédard PJ, Di Paolo T, Julien P, Calon F. 2006. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 48:404-414.
-
(2006)
Neurochem Int
, vol.48
, pp. 404-414
-
-
Julien, C.1
Berthiaume, L.2
Hadj-Tahar, A.3
Rajput, A.H.4
Bédard, P.J.5
Di Paolo, T.6
Julien, P.7
Calon, F.8
-
30
-
-
0033982936
-
KEGG: kyoto encyclopedia of genes and genomes
-
Kanehisa M, Goto S 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27-30.
-
(2000)
Nucleic Acids Res
, vol.28
, Issue.1
, pp. 27-30
-
-
Kanehisa, M.1
Goto, S.2
-
31
-
-
58249113979
-
Endocannabinoid-mediated control of synaptic transmission
-
Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. 2009. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:309-380.
-
(2009)
Physiol Rev
, vol.89
, pp. 309-380
-
-
Kano, M.1
Ohno-Shosaku, T.2
Hashimotodani, Y.3
Uchigashima, M.4
Watanabe, M.5
-
32
-
-
77951665718
-
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses
-
Kim J, Alger BE. 2010. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13:592-600.
-
(2010)
Nat Neurosci
, vol.13
, pp. 592-600
-
-
Kim, J.1
Alger, B.E.2
-
33
-
-
5144228175
-
Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia
-
Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA. 2004. Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia. Neurobiol Dis 17:219-236.
-
(2004)
Neurobiol Dis
, vol.17
, pp. 219-236
-
-
Konradi, C.1
Westin, J.E.2
Carta, M.3
Eaton, M.E.4
Kuter, K.5
Dekundy, A.6
Lundblad, M.7
Cenci, M.A.8
-
35
-
-
67349202050
-
Evaluation of D2 and D3 dopamine receptor selective compounds on l-DOPA-dependent abnormal involuntary movements in rats
-
Kumar R, Riddle LR, Griffin SA, Chu W, Vangveravong S, Neisewander J, Mach RH, Luedtke RR. 2009. Evaluation of D2 and D3 dopamine receptor selective compounds on l-DOPA-dependent abnormal involuntary movements in rats. Neuropharmacology 56:956-969.
-
(2009)
Neuropharmacology
, vol.56
, pp. 956-969
-
-
Kumar, R.1
Riddle, L.R.2
Griffin, S.A.3
Chu, W.4
Vangveravong, S.5
Neisewander, J.6
Mach, R.H.7
Luedtke, R.R.8
-
36
-
-
77349086589
-
l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: Temporal and quantitative relationship to the expression of dyskinesia
-
Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA. 2010. l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: Temporal and quantitative relationship to the expression of dyskinesia. J Neurochem 112:1465-1476.
-
(2010)
J Neurochem
, vol.112
, pp. 1465-1476
-
-
Lindgren, H.S.1
Andersson, D.R.2
Lagerkvist, S.3
Nissbrandt, H.4
Cenci, M.A.5
-
37
-
-
22544438407
-
2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum
-
2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J Neurosci 25:6826-6835.
-
(2005)
J Neurosci
, vol.25
, pp. 6826-6835
-
-
Maejima, T.1
Oka, S.2
Hashimotodani, Y.3
Ohno-Shosaku, T.4
Aiba, A.5
Wu, D.6
Waku, K.7
Sugiura, T.8
Kano, M.9
-
38
-
-
84856516709
-
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
-
Martinez A, Macheda T, Morgese MG, Trabace L, Giuffrida A. 2012. The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neurosci Res 72:236-242.
-
(2012)
Neurosci Res
, vol.72
, pp. 236-242
-
-
Martinez, A.1
Macheda, T.2
Morgese, M.G.3
Trabace, L.4
Giuffrida, A.5
-
39
-
-
33947611555
-
Long-term depression: Multiple forms and implications for brain function
-
Massey PV, Bashir ZI. 2007. Long-term depression: Multiple forms and implications for brain function. Trends Neurosci 30:176-184.
-
(2007)
Trends Neurosci
, vol.30
, pp. 176-184
-
-
Massey, P.V.1
Bashir, Z.I.2
-
40
-
-
33745354666
-
Microarrays in Parkinson's disease: A systematic approach
-
Miller RM, Federoff HJ. 2006. Microarrays in Parkinson's disease: A systematic approach. NeuroRx 3:319-326.
-
(2006)
NeuroRx
, vol.3
, pp. 319-326
-
-
Miller, R.M.1
Federoff, H.J.2
-
41
-
-
35348938494
-
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors
-
Morgese MG, Cassano T, Cuomo V, Giuffrida A. 2007. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors. Exp Neurol 208:110-119.
-
(2007)
Exp Neurol
, vol.208
, pp. 110-119
-
-
Morgese, M.G.1
Cassano, T.2
Cuomo, V.3
Giuffrida, A.4
-
42
-
-
33746105694
-
Continuous dopamine-receptor treatment of Parkinson's disease: Scientific rationale and clinical implications
-
Olanow CW, Obeso JA, Stocchi F. 2006. Continuous dopamine-receptor treatment of Parkinson's disease: Scientific rationale and clinical implications. Lancet Neurol 5:677-687.
-
(2006)
Lancet Neurol
, vol.5
, pp. 677-687
-
-
Olanow, C.W.1
Obeso, J.A.2
Stocchi, F.3
-
43
-
-
84864134369
-
Strong preferences of dopamine and l-DOPA towards lipid head group: Importance of lipid composition and implication for neurotransmitter metabolism
-
Orłowski A, Grzybek M, Bunker A, Pasenkiewicz-Gierula M, Vattulainen I, Männistö PT, Róg T. 2012. Strong preferences of dopamine and l-DOPA towards lipid head group: Importance of lipid composition and implication for neurotransmitter metabolism. J Neurochem 122:681-690.
-
(2012)
J Neurochem
, vol.122
, pp. 681-690
-
-
Orłowski, A.1
Grzybek, M.2
Bunker, A.3
Pasenkiewicz-Gierula, M.4
Vattulainen, I.5
Männistö, P.T.6
Róg, T.7
-
44
-
-
43449092524
-
The cannabinoid system in Parkinson's disease: Multiple targets to motor effects
-
Papa SM. 2008. The cannabinoid system in Parkinson's disease: Multiple targets to motor effects. Exp Neurol 211:334-338.
-
(2008)
Exp Neurol
, vol.211
, pp. 334-338
-
-
Papa, S.M.1
-
46
-
-
0037407907
-
Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia
-
Picconi B, Centonze D, Håkansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. 2003. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat Neurosci 6:501-506.
-
(2003)
Nat Neurosci
, vol.6
, pp. 501-506
-
-
Picconi, B.1
Centonze, D.2
Håkansson, K.3
Bernardi, G.4
Greengard, P.5
Fisone, G.6
Cenci, M.A.7
Calabresi, P.8
-
47
-
-
79551716951
-
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia
-
Picconi B, Bagetta V, Ghiglieri V, Paillè V, Di Filippo M, Pendolino V, Tozzi A, Giampà C, Fusco FR, Sgobio C, Calabresi P. 2011. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 134 (Part 2):375-387.
-
(2011)
Brain
, vol.134
, Issue.PART 2
, pp. 375-387
-
-
Picconi, B.1
Bagetta, V.2
Ghiglieri, V.3
Paillè, V.4
Di Filippo, M.5
Pendolino, V.6
Tozzi, A.7
Giampà, C.8
Fusco, F.R.9
Sgobio, C.10
Calabresi, P.11
-
48
-
-
80052967562
-
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
-
Sidhpura N, Parsons LH. 2011. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 61:1070-1087.
-
(2011)
Neuropharmacology
, vol.61
, pp. 1070-1087
-
-
Sidhpura, N.1
Parsons, L.H.2
-
49
-
-
0031929438
-
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
-
Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JM. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
-
(1998)
Neuroscience
, vol.83
, pp. 393-411
-
-
Tsou, K.1
Brown, S.2
Sañudo-Peña, M.C.3
Mackie, K.4
Walker, J.M.5
-
50
-
-
0035942271
-
Significance analysis of microarrays applied to the ionizing radiation response
-
Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5116-5121
-
-
Tusher, V.G.1
Tibshirani, R.2
Chu, G.3
-
51
-
-
77949912308
-
Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease
-
Wang Y, Zhang Q, Liu J, Ali U, Gui Z, Hui Y, Chen L, Wang T. 2010. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease. Brain Res 1324:54-63.
-
(2010)
Brain Res
, vol.1324
, pp. 54-63
-
-
Wang, Y.1
Zhang, Q.2
Liu, J.3
Ali, U.4
Gui, Z.5
Hui, Y.6
Chen, L.7
Wang, T.8
-
52
-
-
84855306692
-
Genome-wide gene expression analysis suggests an important role of suppressed immunity in pathogenesis of Kashin-Beck disease
-
Wang S, Guo X, Wu XM, Lammi MJ. 2012. Genome-wide gene expression analysis suggests an important role of suppressed immunity in pathogenesis of Kashin-Beck disease. PLoS One 7:e28439.
-
(2012)
PLoS One
, vol.7
-
-
Wang, S.1
Guo, X.2
Wu, X.M.3
Lammi, M.J.4
-
53
-
-
0036070538
-
l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function
-
Winkler C, Kirik D, Björklund A, Cenci MA. 2002. l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 10:165-186.
-
(2002)
Neurobiol Dis
, vol.10
, pp. 165-186
-
-
Winkler, C.1
Kirik, D.2
Björklund, A.3
Cenci, M.A.4
-
54
-
-
79960897042
-
Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease
-
Zhang F, Guo X, Wang W, Yan H, Li C. 2011. Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease. PLoS One 6:e22983.
-
(2011)
PLoS One
, vol.6
-
-
Zhang, F.1
Guo, X.2
Wang, W.3
Yan, H.4
Li, C.5
|